The Vaccine Group announces appointment of Advisory Board

The Vaccine Group (“TVG”) has appointed three high-ranking and well-connected animal health experts to form an advisory board to support scale up of the Company’s novel herpesvirus-based vaccine platform and to forge deeper industry relationships. TVG has made strong progress in establishing a pipeline of vaccines for use in livestock, pets and wildlife to tackle […]

TVG to collaborate on PRRS Immunology Group Grant to Progress Novel PRRS Vaccine

The PRRS Immunology Group at The Pirbright Institute has been awarded an Impact Acceleration Award of £9,000 to progress a novel vaccine for porcine reproductive and respiratory syndrome (PRRS), a major threat to the global pig industry. The grant will support a six-month project led by Dr Rory Fortes de Brito under the mentorship of […]

TVG extends its portfolio of animal vaccine candidates into new disease areas

TVG Working Scientist

The Vaccine Group is expanding its repertoire of vaccine candidates as it seeks to maximise the potential of its platform herpesvirus gene delivery system. Following the move into important diseases of commercial livestock in recent years TVG has now begun to explore the opportunities presented by the companion animal sector. The common element to each […]

TVG Lassa fever vaccine makes progress

Brown mastomys rat sitting up on grass

Most emerging infectious diseases affecting humans in the last century have originated in animal reservoirs and are defined as zoonotic. Lassa fever is a significant zoonotic disease threat to human health in West Africa with an estimated 100,000 to 300,000 cases of disease each year, of which about 5,000 are fatal1. In a recently completed […]

VetHealthGlobal – see you there!

Multicoloured image saying that TVG is attending VetHealthGlobal

Dr Jeremy Salt will be attending the VetHealthGlobal meeting in Prince Edward Island next week. A great opportunity to meet with potential collaborators and investors, alongside insighful industry updates.

TVG successfully completes DARPA-funded transmissible Lassa fever vaccine project

Lassa fever virus

Most emerging infectious diseases affecting humans in the last century originated in animal reservoirs and are defined as zoonotic. Lassa fever is a significant zoonotic disease threat to human health in eight West African countries with between an estimated 100,000 to 300,000 cases of disease each year, of which about 5,000 are fatal1. The reservoir […]

Successful Streptococcus suis vaccine project completion

TVG ECO Pig Image

TVG has completed a successful Anglo-Chinese project backed by the Department of Health and Social Care (DHSC), Innovate UK, and the Chinese Ministry of Science and Technology to develop a cross-protective candidate Streptococcus suis (S suis) vaccine against the most prevalent serotypes 2, 7 and 9. S suis is a major bacterial disease that reduces […]